Publication not explained

This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.

If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.

Featured Image

Read the Original

This page is a summary of: Efficacy and Safety of 0.6% Pazufloxacin Ophthalmic Solution Versus Moxifloxacin 0.5% and Gatifloxacin 0.3% in Subjects with Bacterial Conjunctivitis: A Randomized Clinical Trial, Journal of Ocular Pharmacology and Therapeutics, April 2018, Mary Ann Liebert Inc,
DOI: 10.1089/jop.2017.0056.
You can read the full text:

Read

Contributors

The following have contributed to this page